Gene42, a UTEST company from the 2015 cohort, recently launched Genomics4RD, Canada’s first national rare disease research platform, in partnership with research association Care4Rare. Care4Rare and Gene42 built Genomics4RD as part of a national initiative funded by Genome Canada. The project is focused on employing multi-omics, an approach to biological analysis, to deliver diagnostic care for rare genetic… Read more »
Welcome to the University of Toronto Early Stage Technology (UTEST) Program.
AmacaThera a UTEST company from 2015, has raised $3.25 million to develop a gel-based drug delivery system that could eliminate the need to give patients powerful painkillers following surgery – a key source of the current opioid crisis. The startup, AmacaThera, is built on a gel technology developed in the U of T lab of Molly Shoichet, Ontario’s… Read more »
UTEST company (cohort 2015), Blue J Legal has raised $9.3 million CAD in a series A round. The round was led by Relay Ventures, with participation from US-based LDV Partners, and returning investors BDC Capital and Mistral Venture Partners. Mistral made an undisclosed investment Blue J Legal in May 2017, though at the time the firm said it… Read more »
Appulse Power Inc., a UTEST company from 2014, founded by U of T Engineering alumni Ahsan Zaman, Behzad Mahdavikhah, Aleksandar Radić, and Professor Aleksandar Prodić has been acquired by the multinational Silanna Semiconductor for an undisclosed amount. “The success of Appulse is credit to the incredible talent and dedication of my three co-founders,” says Professor Prodić. “This team has brought us… Read more »